Your browser doesn't support javascript.
loading
Switching from infliximab originator to a first biosimilar is safe and effective. Results of a case-control study with drug levels and antibodies evaluation.
Guiotto, Cristina; Italia, Angelo; Lavagna, Alessandro; Rigazio, Caterina; Cosimato, Maurizio; Ercole, Elena; Mendolaro, Marco; Rocca, Rodolfo; Daperno, Marco.
  • Guiotto C; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Italia A; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Lavagna A; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Rigazio C; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Cosimato M; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Ercole E; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Mendolaro M; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Rocca R; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
  • Daperno M; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy. Electronic address: mdaperno@gmail.com.
Dig Liver Dis ; 51(8): 1117-1122, 2019 08.
Article en En | MEDLINE | ID: mdl-31272935

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Sustitución de Medicamentos / Infliximab / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Sustitución de Medicamentos / Infliximab / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article